Linked Life Data

12658964

Source:http://linkedlifedata.com/resource/pubmed/id/12658964

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3-4
pubmed:dateCreated
2003-3-27
pubmed:abstractText
Increasing expenditures of health care systems in industrialised western countries are caused by chronic diseases. Hence, issues on the cost-effectiveness of private as well as public financial resources for asthma therapy in children are gaining importance. In order to study cost-effectiveness issues of defining outcome-measures as well as the reliability and validity of methods to assess these outcomes have to be addressed. Data on direct and indirect costs of asthma have to be gathered. In a first step, comparative costs of asthma therapy of children in Germany, Switzerland and Austria have to be analysed. Subsequently, a randomised, prospective study will be able to demonstrate, whether treatment according to national evidence-based guidelines will be more cost-effective than treatment not taking guidelines into account. Data on the cost-effectiveness of therapy guidelines will help in decision-making of national health care authorities.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0043-5341
pubmed:author
pubmed:issnType
Print
pubmed:volume
153
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
59-64
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
[Concepts in studying cost effectiveness of pediatric asthma treatment in Germany, Switzerland and Austria].
pubmed:affiliation
Universitätsklinik für Kinder- und Jugendheilkunde, Wahringer Gürtel 18-20, A-1090 Wien. thomas.frischer@akh-wien.ac.at
pubmed:publicationType
Journal Article, English Abstract, Research Support, Non-U.S. Gov't